These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3958969)

  • 21. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV; Sabitha KE; Shyamaladevi CS
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
    Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic treatment with spirapril on biochemical parameters in streptozotocin-diabetic and spontaneously hypertensive rats.
    Parulekar AA; Hakim ZS; Santani DD; Goyal RK
    Indian J Exp Biol; 1997 Nov; 35(11):1182-6. PubMed ID: 9567746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment.
    Zobali F; Avci A; Canbolat O; Karasu C
    Cell Biochem Funct; 2002 Jun; 20(2):75-80. PubMed ID: 11979500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.
    El-Helou V; Proulx C; Béguin P; Assimakopoulos J; Gosselin H; Clement R; Villeneuve L; Huot-Marchand JE; Deblois D; Lajoie C; Calderone A
    J Cell Physiol; 2009 Aug; 220(2):440-9. PubMed ID: 19388005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Balaraman R
    Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A; Karasu C; Aktan F; Ozansoy G
    Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats.
    Yamaguchi M; Uchiyama S; Lai YL
    Int J Mol Med; 2007 May; 19(5):803-7. PubMed ID: 17390086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats.
    El-Sayed el-SM; Abo-Salem OM; Aly HA; Mansour AM
    Pak J Pharm Sci; 2009 Apr; 22(2):168-74. PubMed ID: 19339227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction.
    Rodrigues B; Grassby PF; Battell ML; Lee SY; McNeill JH
    Can J Physiol Pharmacol; 1994 May; 72(5):447-55. PubMed ID: 7954071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of urethane on hydralazine-induced tachycardia in rats.
    Orallo F; Fontenla JA; Loza MI; Campos M; Calleja JM
    Gen Pharmacol; 1992 Nov; 23(6):1143-7. PubMed ID: 1487125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats.
    Shah TS; Satia MC; Gandhi TP; Bangaru RA; Goyal RK
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):6-12. PubMed ID: 7564366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of vanadate on alloxan-diabetic rat atria.
    Ozcelikay AT; Yidizoglu-Ari N; Ozuari A; Oztürk Y; Altan VM
    Diabetes Res Clin Pract; 1993 Mar; 19(3):189-94. PubMed ID: 8319517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in cardiac function in streptozotocin-diabetic rats by salt loading.
    Dai S; Fraser H; Yuen VG; McNeill JH
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1288-93. PubMed ID: 7767868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of myo-inositol and T3 on myocardial lipids and cardiac function in streptozocin-induced diabetic rats.
    Xiang H; Heyliger CE; McNeill JH
    Diabetes; 1988 Nov; 37(11):1542-8. PubMed ID: 3181644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial metabolic effects of in vivo hydralazine treatment of streptozotocin-diabetic rats.
    Burns AH; Burns LA; Jurenka LU; Summer WR
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H516-21. PubMed ID: 1996694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T3 treatment does not prevent myocardial dysfunction in chronically diabetic rats.
    Barbee RW; Shepherd RE; Burns AH
    Am J Physiol; 1988 Feb; 254(2 Pt 2):H265-73. PubMed ID: 2830793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats.
    Patel SS; Goyal RK
    Pharmacognosy Res; 2011 Oct; 3(4):239-45. PubMed ID: 22224046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of triiodothyronine and carnitine therapy on myocardial dysfunction in diabetic rats.
    Tahiliani AG; McNeill JH
    Can J Physiol Pharmacol; 1986 Jun; 64(6):669-72. PubMed ID: 3756616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by hydralazine of the conversion of dopamine to noradrenaline in rat atria in vitro and in vivo.
    Songkittiguna P; Majewski H; Rand MJ
    Clin Exp Pharmacol Physiol; 1980; 7(5):509-14. PubMed ID: 7449192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.